» Articles » PMID: 15207816

Regulation of PDGF and Its Receptors in Fibrotic Diseases

Overview
Date 2004 Jun 23
PMID 15207816
Citations 301
Authors
Affiliations
Soon will be listed here.
Abstract

Platelet-derived growth factor (PDGF) isoforms play a major role in stimulating the replication, survival, and migration of myofibroblasts during the pathogenesis of fibrotic diseases. During fibrogenesis, PDGF is secreted by a variety of cell types as a response to injury, and many pro-inflammatory cytokines mediate their mitogenic effects via the autocrine release of PDGF. PDGF action is determined by the relative expression of PDGF alpha-receptors (PDGFRalpha) and beta-receptors (PDGFRbeta) on the surface of myofibroblasts. These receptors are induced during fibrogenesis, thereby amplifying biological responses to PDGF isoforms. PDGF action is also modulated by extracellular binding proteins and matrix molecules. This review summarizes the literature on the role of PDGF and its receptors in the development of fibrosis in a variety of organ systems, including lung, liver, kidney, and skin.

Citing Articles

Identification of early genes in the pathophysiology of fibrotic interstitial lung disease in a new model of pulmonary fibrosis.

Hennion N, Bedart C, Vandomber L, Gottrand F, Humez S, Chenivesse C Cell Mol Life Sci. 2025; 82(1):115.

PMID: 40074941 PMC: 11904048. DOI: 10.1007/s00018-025-05620-0.


Reduced tracheal stenosing effect of nintedanib in a patient with scarred posttraumatic tracheal stenosis and airflow limitation - a case report.

Klampfleitner S, Fertl A, Prinz O, Doerfler-Schalm M, Munker D, Henke M Respir Med Case Rep. 2025; 54:102168.

PMID: 40007765 PMC: 11849196. DOI: 10.1016/j.rmcr.2025.102168.


Low-Grade Inflammation in Long COVID Syndrome Sustains a Persistent Platelet Activation Associated With Lung Impairment.

Brambilla M, Fumoso F, Conti M, Becchetti A, Bozzi S, Mencarini T JACC Basic Transl Sci. 2025; 10(1):20-39.

PMID: 39958473 PMC: 11830264. DOI: 10.1016/j.jacbts.2024.09.007.


Advances and challenges in kidney fibrosis therapeutics.

Abbad L, Esteve E, Chatziantoniou C Nat Rev Nephrol. 2025; .

PMID: 39934355 DOI: 10.1038/s41581-025-00934-5.


Macrophages in organ fibrosis: from pathogenesis to therapeutic targets.

Jiang Y, Cai R, Huang Y, Zhu L, Xiao L, Wang C Cell Death Discov. 2024; 10(1):487.

PMID: 39632841 PMC: 11618518. DOI: 10.1038/s41420-024-02247-1.